Ryan Williams
Neurology with Special Qualifications in Child Neurology · Norfolk, VANPI 1437461977
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $2,898 of the $4,473 with a category attached, or 64.8%. 15 manufacturers reported payments, led by Lundbeck LLC at 32.4% of the total. 2025 is the largest year on record at $2,469, more than ten times the $241 reported in 2019.
Across 49 payments — averaging $91.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lundbeck LLC$1K
- Livanova USA, Inc.$1K
- UCB, Inc.$525
- Supernus Pharmaceuticals, Inc.$363
- Neurelis, Inc.$218
- Amgen$125
- plus $773 from 9 others
Across 184 payments — averaging $2989.14 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Amgen$234K
- Teva Pharmaceuticals USA, Inc.$223K
- AbbVie$36K
- H. Lundbeck A S$22K
- Eli Lilly$15K
- Biohaven Pharmaceutical Holding Company Ltd.$13K
- plus $6K from 1 others
What the payments were for
- Consulting fees$1,27529%
- Travel & lodging$3007%
- Food & beverage$2,89865%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lundbeck LLC | 4 | $1,451 |
| Livanova USA, Inc. | 11 | $1,018 |
| UCB, Inc. | 9 | $525 |
| Supernus Pharmaceuticals, Inc. | 10 | $363 |
| Neurelis, Inc. | 3 | $218 |
| Amgen | 1 | $125 |
| Novartis | 1 | $117 |
| Sunovion Pharmaceuticals Inc. | 1 | $116 |
| Biomarin Pharmaceutical Inc. | 1 | $115 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $113 |
| Axsome Therapeutics, Inc. | 1 | $94 |
| Lilly USA, LLC | 2 | $79 |
| AbbVie(2 entities) | 2 | $63 |
| Collegium Pharmaceutical, Inc. | 1 | $52 |
| Aquestive Therapeutics, Inc. | 1 | $25 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VYEPTI$1,400
- VNS Therapy$682
- VNS THERAPY SENTIVA MODEL 1000 GENERATOR$240
- QELBREE$149
- Fintepla$129
- AIMOVIG$125
- Nayzilam$125
- Briviact$124
- AFINITOR$117
- APTIOM$116
- Brineura$115
- NURTEC ODT$113
- VALTOCO$107
How this compares
$4,473 in reported general payments places this provider in the 65th percentile of 23 neurology with special qualifications in child neurology providers in Virginia.
See all neurology with special qualifications in child neurology providers in Virginia →
Other neurology with special qualifications in child neurology in Norfolk
- Crystal ProudNorfolk$1M
- Michael StruncNorfolk$639K
- Georg DahlNorfolk$2K
- Ralph NorthamNorfolk$2K
- Ludwig FrankNorfolk$1K
- Svinder ToorNorfolk$139
- Mathula ThangarajhRichmond$47K
- Amy HarperRichmond$46K
- Lawrence MortonRichmond$17K
- Alison AlfordRichmond$13K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.